Ketorolac use in the pediatric surgical patient: An Evidence-Based Practice analysis
Jason Beach, DNAP, CRNA
- Sigma Affiliation
Visits vs Downloads
Visitors - World Map
Top Visiting Countries
Top Visiting Cities
Visits (last 6 months)
Downloads (last 6 months)
Popular Works for Beach, Jason by View
Popular Works for Beach, Jason by Download
Opioid-based medications are often the first medications selected for pain control in young patients; however opioids possess several unwanted side effects such as respiratory depression, nausea, vomiting and allergic reactions. Administration of medications that support a multimodal approach to pain management is imperative. It is a longstanding belief that pediatric pain is significantly undertreated due to providers’ hesitance to use non-steroidal anti-inflammatory drugs (NSAIDs). Baley et al.1 cite that anesthesia providers have been challenged to eliminate the under treatment of pain in the pediatric population. The pediatric population is at high risk for inadequate pain management and providers should strongly consider adjunct medications in the treatment of pain.
|Type||Other Graduate Paper|
|Review Type||Faculty Approved: Degree-based Submission|
Ketorolac--Administration and Dosage;
Ketorolac--Therapeutic Use--In Infancy and Childhood;
Postoperative Pain--Drug Therapy--In Infancy and Childhood;
Postoperative Pain--Drug Therapy;
Platelet Aggregation--Drug Effects
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
The following license files are associated with this item: